Shopping Cart 0
Cart Subtotal
AED 0

Global Immune Repertoire Sequencing Market Size study, by Type (Assay Kits, Software & Services), by Application (Biomarker Discovery, Infectious Diseases, Vaccine Development & Efficacy, Cancer Immunotherapy, Autoimmune Diseases, Transplant Rejection & Tolerance, Others), by End-User (Academic Institutes, Research Center Diagnostic Laboratories, Others) and Regional Forecasts 2018-2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 14497

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 20369

Details

Global Immune Repertoire Sequencing Market to reach USD XX billion by 2025.
 
Global Immune Repertoire Sequencing Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. Immune repertoire is sub-type of proteins on organism's immune system creates. Immune repertoire sequencing allows scientist and researchers to inspect and recognize the adoptive immune-mediated diseases. Immune repertoire sequencing is also widely accepted in cancer immunotherapy, biomarker discovery, asthma and allergy research and infectious diseases research. Increasing research & development, increasing prevalence of cancer and new launches of novel products are the driving factors of the immune repertoire sequencing market across the globe. In addition, increasing international collaboration in immune repertoire sequencing projects is creating a numerous opportunity in the market over the upcoming years. However, lack of awareness about the about the cancer diseases treatment and high cost related with sequencing platform & data analytics services are the restraining factor of the market across the globe.
The regional analysis of Global Immune Repertoire Sequencing Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasingly focus on developing novel technologies and high presence of key players in the region. Europe is also estimated to grow in market due to rapid growth in immune repertoire sequencing in the region over the forecast period. Asia-Pacific is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 due to increasing usage of immune repertoire sequencing in oncology research in the region. High prevalence of infectious diseases is substantial driver for growth of immune repertoire sequencing market in Middle East and Africa.
The market player included in this report are:
Illumina Inc.
Pacific Biosciences of California Inc.
Agilent Technologies
Oxford Nanopore Technologies Ltd.
QIAGEN N.V.
Thermo Fischer Scientific
Hoffmann-La Roche Ltd.
BGI
Takara Bio Inc.
 
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
 
By Type:
 
Assay Kits
Software & Services
 
By Application:
 
Biomarker Discovery
Infectious Diseases
Vaccine Development & Efficacy
Cancer Immunotherapy
Autoimmune Diseases
Transplant Rejection & Tolerance
Others
 
By End-User:
 
Academic Institutes
Research Center Diagnostic Laboratories
Others
 
By Regions:
North America
o U.S.
o Canada
Europe
o UK
o Germany
Asia Pacific
o China
o India
o Japan
Latin America
o Brazil
o Mexico
Rest of the World
 
Furthermore, years considered for the study are as follows:
 
Historical year - 2015, 2016
Base year - 2017
Forecast period - 2018 to 2025
 
Target Audience of the Global Immune Repertoire Sequencing Market in Market Study:
 
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
READ MORE

Table Of Content

Scope

TABLE OF CONTENTS

 

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Key Trends

1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

1.3.1. Immune Repertoire Sequencing Market, by Type, 2015-2025 (USD Billion)

1.3.2. Immune Repertoire Sequencing Market, by Application, 2015-2025 (USD Billion)

1.3.3. Immune Repertoire Sequencing Market, by End-User, 2015-2025 (USD Billion)

1.3.4. Immune Repertoire Sequencing Market, by Region, 2015-2025 (USD Billion)

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Immune Repertoire Sequencing Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Industry Evolution

2.2.2. Scope of the Study

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Immune Repertoire Sequencing Market Dynamics

3.1. See Saw Analysis

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Immune Repertoire Sequencing Market Industry Analysis

4.1. Porter's 5 Force Model

4.1.1. Bargaining Power of Buyers

4.1.2. Bargaining Power of Suppliers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter's 5 Force Model

4.2. PEST Analysis

4.2.1. Political Scenario

4.2.2. Economic Scenario

4.2.3. Social Scenario

4.2.4. Technological Scenario

4.3. Value Chain Analysis

4.3.1. Supplier

4.3.2. Manufacturers/Service Provider

4.3.3. Distributors

4.3.4. End-Users

4.4. Key Buying Criteria

4.5. Regulatory Framework

4.6. Cost Structure Analysis

4.6.1. Raw Material Cost Analysis

4.6.2. Manufacturing Cost Analysis

4.6.3. Labor Cost Analysis

4.7. Investment Vs Adoption Scenario

4.8. Analyst Recommendation & Conclusion

Chapter 5. Immune Repertoire Sequencing Market, by Type

5.1. Market Snapshot

5.2. Market Performance - Potential Model

5.3. Key Market Players

5.4. Immune Repertoire Sequencing Market, Sub Segment Analysis

5.4.1. Assay Kits

5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.4.2. Software & Services

5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Immune Repertoire Sequencing Market, by Application

6.1. Market Snapshot

6.2. Market Performance - Potential Model

6.3. Key Market Players

6.4. Immune Repertoire Sequencing Market, Sub Segment Analysis

6.4.1. Biomarker Discovery

6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.2. Infectious Diseases

6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.3. Vaccine Development and Efficacy

6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.4. Cancer Immunotherapy

6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.5. Autoimmune Diseases

6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.6. Transplant Rejection and Tolerance

6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.7. Others

6.4.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Immune Repertoire Sequencing Market, by End-User

7.1. Market Snapshot

7.2. Market Performance - Potential Model

7.3. Key Market Players

7.4. Immune Repertoire Sequencing Market, Sub Segment Analysis

7.4.1. Academic Institutes

7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2. Research Centers Diagnostic Laboratories

7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3. Others

7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Immune Repertoire Sequencing Market, by Regional Analysis

8.1. Immune Repertoire Sequencing Market, Regional Market Snapshot (2015-2025)

8.2. North America Immune Repertoire Sequencing Market Snapshot

8.2.1. U.S.

8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2. Canada

8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3. Europe Immune Repertoire Sequencing Market Snapshot

8.3.1. U.K.

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2. Germany

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3. France

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4. Rest of Europe

8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4. Asia Immune Repertoire Sequencing Market Snapshot

8.4.1. China

8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2. India

8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3. Japan

8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4. Rest of Asia Pacific

8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5. Latin America Immune Repertoire Sequencing Market Snapshot

8.5.1. Brazil

8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2. Mexico

8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6. Rest of The World

8.6.1. South America

8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2. Middle East and Africa

8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Competitive Intelligence

9.1. Company Market Share (Subject to Data Availability)

9.2. Top Market Strategies

9.3. Company Profiles

9.3.1. Illumina Inc.

9.3.1.1. Overview

9.3.1.2. Financial (Subject to Data Availability)

9.3.1.3. Product Summary

9.3.1.4. Recent Developments

9.3.2. Pacific Biosciences of California Inc.

9.3.3. Agilent Technologies

9.3.4. Oxford Nanopore Technologies Ltd.

9.3.5. QIAGEN N.V.

9.3.6. Thermo Fischer Scientific

9.3.7. Hoffmann-La Roche Ltd.

9.3.8. BGI

9.3.9. Takara Bio Inc.

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.1.6. Research Assumption


List Of Figure

FIG 1. IMMUNE REPERTOIRE SEQUENCING MARKET, RESEARCH METHODOLOGY

FIG 2. IMMUNE REPERTOIRE SEQUENCING MARKET, MARKET ESTIMATION TECHNIQUES

FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS

FIG 4. IMMUNE REPERTOIRE SEQUENCING MARKET, KEY TRENDS 2016

FIG 5. IMMUNE REPERTOIRE SEQUENCING MARKET, GROWTH PROSPECTS 2017-2025

FIG 6. IMMUNE REPERTOIRE SEQUENCING MARKET, PORTERS 5 FORCE MODEL

FIG 7. IMMUNE REPERTOIRE SEQUENCING MARKET, PEST ANALYSIS

FIG 8. IMMUNE REPERTOIRE SEQUENCING MARKET, VALUE CHAIN ANALYSIS

FIG 9. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 10. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 11. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 12. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 13. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 14. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 15. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 16. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 17. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 18. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 19. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 20. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 21. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 22. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 23. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 24. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 25. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 26. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 27. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 28. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 29. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 30. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 31. IMMUNE REPERTOIRE SEQUENCING MARKET, REGIONAL SNAPSHOT 2015 & 2025

FIG 32. NORTH AMERICA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET 2015 & 2025 (USD BILLION)

FIG 33. EUROPE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET 2015 & 2025 (USD BILLION)

FIG 34. ASIA PACIFIC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET 2015 & 2025 (USD BILLION)

FIG 35. LATIN AMERICA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET 2015 & 2025 (USD BILLION)

FIG 36. IMMUNE REPERTOIRE SEQUENCING MARKET, COMPANY MARKET SHARE ANALYSIS (2016)


List Of Table

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF IMMUNE REPERTOIRE SEQUENCING MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF IMMUNE REPERTOIRE SEQUENCING MARKET

TABLE 3. IMMUNE REPERTOIRE SEQUENCING MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. IMMUNE REPERTOIRE SEQUENCING MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)

TABLE 7. IMMUNE REPERTOIRE SEQUENCING MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)

TABLE 8. IMMUNE REPERTOIRE SEQUENCING MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)

TABLE 9. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 10. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 11. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 12. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 13. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 14. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 15. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 16. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 17. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 18. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 19. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 20. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 21. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 22. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 23. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 24. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 25. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 26. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 27. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 28. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 29. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 30. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 31. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 32. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 33. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 34. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 35. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 36. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 37. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 38. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 39. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 40. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 41. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 42. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 43. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 44. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 45. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 46. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 47. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 48. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 49. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 50. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 51. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 52. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 53. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 54. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 55. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 56. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 57. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 58. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 59. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 60. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 61. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 62. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 63. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 64. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 65. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 66. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 67. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 68. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 69. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 70. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 71. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 72. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 73. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 74. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 75. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 76. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 77. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 78. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 79. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 80. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 81. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 82. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 83. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 84. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 85. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 86. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 87. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 88. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 89. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 90. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 91. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 92. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 93. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 94. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 95. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 96. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 97. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 98. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 99. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 100. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 101. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 102. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 103. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 104. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 105. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 106. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 107. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 108. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 109. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Illumina Inc.

Pacific Biosciences of California Inc.

Agilent Technologies

Oxford Nanopore Technologies Ltd.

QIAGEN N.V.

Thermo Fischer Scientific

Hoffmann-La Roche Ltd.

BGI

Takara Bio Inc.

Company Profile

Company Profile Title

Global Immune Repertoire Sequencing Market to reach USD XX billion by 2025.
 
Global Immune Repertoire Sequencing Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. Immune repertoire is sub-type of proteins on organism's immune system creates. Immune repertoire sequencing allows scientist and researchers to inspect and recognize the adoptive immune-mediated diseases. Immune repertoire sequencing is also widely accepted in cancer immunotherapy, biomarker discovery, asthma and allergy research and infectious diseases research. Increasing research & development, increasing prevalence of cancer and new launches of novel products are the driving factors of the immune repertoire sequencing market across the globe. In addition, increasing international collaboration in immune repertoire sequencing projects is creating a numerous opportunity in the market over the upcoming years. However, lack of awareness about the about the cancer diseases treatment and high cost related with sequencing platform & data analytics services are the restraining factor of the market across the globe.
The regional analysis of Global Immune Repertoire Sequencing Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasingly focus on developing novel technologies and high presence of key players in the region. Europe is also estimated to grow in market due to rapid growth in immune repertoire sequencing in the region over the forecast period. Asia-Pacific is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 due to increasing usage of immune repertoire sequencing in oncology research in the region. High prevalence of infectious diseases is substantial driver for growth of immune repertoire sequencing market in Middle East and Africa.
The market player included in this report are:
Illumina Inc.
Pacific Biosciences of California Inc.
Agilent Technologies
Oxford Nanopore Technologies Ltd.
QIAGEN N.V.
Thermo Fischer Scientific
Hoffmann-La Roche Ltd.
BGI
Takara Bio Inc.
 
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
 
By Type:
 
Assay Kits
Software & Services
 
By Application:
 
Biomarker Discovery
Infectious Diseases
Vaccine Development & Efficacy
Cancer Immunotherapy
Autoimmune Diseases
Transplant Rejection & Tolerance
Others
 
By End-User:
 
Academic Institutes
Research Center Diagnostic Laboratories
Others
 
By Regions:
North America
o U.S.
o Canada
Europe
o UK
o Germany
Asia Pacific
o China
o India
o Japan
Latin America
o Brazil
o Mexico
Rest of the World
 
Furthermore, years considered for the study are as follows:
 
Historical year - 2015, 2016
Base year - 2017
Forecast period - 2018 to 2025
 
Target Audience of the Global Immune Repertoire Sequencing Market in Market Study:
 
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
READ MORE

Scope

TABLE OF CONTENTS

 

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Key Trends

1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

1.3.1. Immune Repertoire Sequencing Market, by Type, 2015-2025 (USD Billion)

1.3.2. Immune Repertoire Sequencing Market, by Application, 2015-2025 (USD Billion)

1.3.3. Immune Repertoire Sequencing Market, by End-User, 2015-2025 (USD Billion)

1.3.4. Immune Repertoire Sequencing Market, by Region, 2015-2025 (USD Billion)

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Immune Repertoire Sequencing Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Industry Evolution

2.2.2. Scope of the Study

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Immune Repertoire Sequencing Market Dynamics

3.1. See Saw Analysis

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Immune Repertoire Sequencing Market Industry Analysis

4.1. Porter's 5 Force Model

4.1.1. Bargaining Power of Buyers

4.1.2. Bargaining Power of Suppliers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter's 5 Force Model

4.2. PEST Analysis

4.2.1. Political Scenario

4.2.2. Economic Scenario

4.2.3. Social Scenario

4.2.4. Technological Scenario

4.3. Value Chain Analysis

4.3.1. Supplier

4.3.2. Manufacturers/Service Provider

4.3.3. Distributors

4.3.4. End-Users

4.4. Key Buying Criteria

4.5. Regulatory Framework

4.6. Cost Structure Analysis

4.6.1. Raw Material Cost Analysis

4.6.2. Manufacturing Cost Analysis

4.6.3. Labor Cost Analysis

4.7. Investment Vs Adoption Scenario

4.8. Analyst Recommendation & Conclusion

Chapter 5. Immune Repertoire Sequencing Market, by Type

5.1. Market Snapshot

5.2. Market Performance - Potential Model

5.3. Key Market Players

5.4. Immune Repertoire Sequencing Market, Sub Segment Analysis

5.4.1. Assay Kits

5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.4.2. Software & Services

5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Immune Repertoire Sequencing Market, by Application

6.1. Market Snapshot

6.2. Market Performance - Potential Model

6.3. Key Market Players

6.4. Immune Repertoire Sequencing Market, Sub Segment Analysis

6.4.1. Biomarker Discovery

6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.2. Infectious Diseases

6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.3. Vaccine Development and Efficacy

6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.4. Cancer Immunotherapy

6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.5. Autoimmune Diseases

6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.6. Transplant Rejection and Tolerance

6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.7. Others

6.4.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Immune Repertoire Sequencing Market, by End-User

7.1. Market Snapshot

7.2. Market Performance - Potential Model

7.3. Key Market Players

7.4. Immune Repertoire Sequencing Market, Sub Segment Analysis

7.4.1. Academic Institutes

7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2. Research Centers Diagnostic Laboratories

7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3. Others

7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Immune Repertoire Sequencing Market, by Regional Analysis

8.1. Immune Repertoire Sequencing Market, Regional Market Snapshot (2015-2025)

8.2. North America Immune Repertoire Sequencing Market Snapshot

8.2.1. U.S.

8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2. Canada

8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3. Europe Immune Repertoire Sequencing Market Snapshot

8.3.1. U.K.

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2. Germany

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3. France

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4. Rest of Europe

8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4. Asia Immune Repertoire Sequencing Market Snapshot

8.4.1. China

8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2. India

8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3. Japan

8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4. Rest of Asia Pacific

8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5. Latin America Immune Repertoire Sequencing Market Snapshot

8.5.1. Brazil

8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2. Mexico

8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6. Rest of The World

8.6.1. South America

8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2. Middle East and Africa

8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Competitive Intelligence

9.1. Company Market Share (Subject to Data Availability)

9.2. Top Market Strategies

9.3. Company Profiles

9.3.1. Illumina Inc.

9.3.1.1. Overview

9.3.1.2. Financial (Subject to Data Availability)

9.3.1.3. Product Summary

9.3.1.4. Recent Developments

9.3.2. Pacific Biosciences of California Inc.

9.3.3. Agilent Technologies

9.3.4. Oxford Nanopore Technologies Ltd.

9.3.5. QIAGEN N.V.

9.3.6. Thermo Fischer Scientific

9.3.7. Hoffmann-La Roche Ltd.

9.3.8. BGI

9.3.9. Takara Bio Inc.

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.1.6. Research Assumption


List Of Figure

FIG 1. IMMUNE REPERTOIRE SEQUENCING MARKET, RESEARCH METHODOLOGY

FIG 2. IMMUNE REPERTOIRE SEQUENCING MARKET, MARKET ESTIMATION TECHNIQUES

FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS

FIG 4. IMMUNE REPERTOIRE SEQUENCING MARKET, KEY TRENDS 2016

FIG 5. IMMUNE REPERTOIRE SEQUENCING MARKET, GROWTH PROSPECTS 2017-2025

FIG 6. IMMUNE REPERTOIRE SEQUENCING MARKET, PORTERS 5 FORCE MODEL

FIG 7. IMMUNE REPERTOIRE SEQUENCING MARKET, PEST ANALYSIS

FIG 8. IMMUNE REPERTOIRE SEQUENCING MARKET, VALUE CHAIN ANALYSIS

FIG 9. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 10. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 11. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 12. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 13. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 14. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 15. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 16. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 17. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 18. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 19. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 20. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 21. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 22. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 23. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 24. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 25. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 26. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 27. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 28. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 29. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 30. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 31. IMMUNE REPERTOIRE SEQUENCING MARKET, REGIONAL SNAPSHOT 2015 & 2025

FIG 32. NORTH AMERICA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET 2015 & 2025 (USD BILLION)

FIG 33. EUROPE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET 2015 & 2025 (USD BILLION)

FIG 34. ASIA PACIFIC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET 2015 & 2025 (USD BILLION)

FIG 35. LATIN AMERICA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET 2015 & 2025 (USD BILLION)

FIG 36. IMMUNE REPERTOIRE SEQUENCING MARKET, COMPANY MARKET SHARE ANALYSIS (2016)


List Of Table

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF IMMUNE REPERTOIRE SEQUENCING MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF IMMUNE REPERTOIRE SEQUENCING MARKET

TABLE 3. IMMUNE REPERTOIRE SEQUENCING MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. IMMUNE REPERTOIRE SEQUENCING MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)

TABLE 7. IMMUNE REPERTOIRE SEQUENCING MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)

TABLE 8. IMMUNE REPERTOIRE SEQUENCING MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)

TABLE 9. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 10. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 11. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 12. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 13. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 14. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 15. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 16. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 17. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 18. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 19. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 20. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 21. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 22. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 23. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 24. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 25. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 26. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 27. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 28. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 29. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 30. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 31. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 32. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 33. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 34. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 35. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 36. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 37. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 38. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 39. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 40. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 41. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 42. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 43. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 44. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 45. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 46. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 47. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 48. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 49. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 50. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 51. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 52. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 53. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 54. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 55. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 56. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 57. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 58. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 59. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 60. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 61. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 62. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 63. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 64. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 65. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 66. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 67. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 68. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 69. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 70. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 71. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 72. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 73. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 74. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 75. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 76. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 77. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 78. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 79. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 80. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 81. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 82. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 83. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 84. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 85. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 86. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 87. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 88. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 89. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 90. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 91. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 92. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 93. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 94. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 95. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 96. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 97. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 98. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 99. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 100. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 101. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 102. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 103. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 104. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 105. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 106. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 107. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 108. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 109. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Illumina Inc.

Pacific Biosciences of California Inc.

Agilent Technologies

Oxford Nanopore Technologies Ltd.

QIAGEN N.V.

Thermo Fischer Scientific

Hoffmann-La Roche Ltd.

BGI

Takara Bio Inc.